Vascular endothelial growth factor (VEGF) – a valuable serum tumour marker in patients with colorectal cancer?
- 28 February 2001
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 27 (1) , 37-42
- https://doi.org/10.1053/ejso.2000.1052
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancerEuropean Journal Of Cancer, 1998
- Concentrations of vascular endothelial growth factor in the sera of gastric cancer patients.Oncology Reports, 1998
- Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancerBritish Journal of Cancer, 1998
- Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biologyBritish Journal of Cancer, 1998
- Circulating Vascular Endothelial Growth Factor in Patients With Colorectal CancerAmerican Journal of Gastroenterology, 1998
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and plateletsProceedings of the National Academy of Sciences, 1997
- Assignment of the Vascular Endothelial Growth Factor Gene to Human Chromosome 6p21.3Circulation, 1996
- High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesisCell, 1993
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992